SCHEMBL5737091

SCHEMBL5737091

[C]1=CC2Sc3ccccc3C=CC2C=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4190469 0.76 ALOX5 (0.32)
SCHEMBL3077211 0.74 IDO1 (0.30)
SCHEMBL365987 0.65 GAA (0.34)
SCHEMBL10442401 0.64
SCHEMBL21383118 0.64
SCHEMBL24265597 0.64 MEN1 (0.31)
SCHEMBL31301082 0.64
SCHEMBL3074983 0.64 IDO1 (0.36)
SCHEMBL3074714 0.64 HTR6 (0.30)
SCHEMBL3833168 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0837052-B1 BICYCLIC AMINO DERIVATIVES AND PGD 2 ANTAGONIST CONTAINING THE SAME SHIONOGI & CO (JP) 2006-08-23 EP disclosed
US-6498190-B1 TREATMENT OF NASAL OCCLUSION AND MAST CELL DYSFUNCTION DISEASES; ANTIINFLAMMATORY AGENTS SHIONOGI & CO., LTD. (JP) 2002-12-24 US disclosed
US-6384075-B1 TREATING DISEASES IN WHICH MAST CELL DYSFUNCTION IS INVOLVED SHIONOGI & CO., LTD. (JP) 2002-05-07 US disclosed
US-6172113-B1 Bicyclic amino derivatives and PGD2 antagonist containing the same SHIONOGI & CO., LTD. (JP) 2001-01-09 US disclosed
EP-0837052-A1 BICYCLIC AMINO DERIVATIVES AND PGD 2 ANTAGONIST CONTAINING THE SAME SHIONOGI & CO., LTD. (JP) 1998-04-22 EP disclosed